Growth hormone treatment of idiopathic short stature

Hormone Research in Paediatrics

Volumn 46, Issue 4-5, 1996, Pages 208-214

  Hintz, Raymond L ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Growth hormone; Short stature; Therapy; Trial

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

BODY HEIGHT; BONE AGE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HEALTH CARE COST; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE;

ADULT; BODY HEIGHT; CHILD; HUMAN GROWTH HORMONE; HUMANS; PROGNOSIS;

EID: 0029842531     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185025     Document Type: Article

References (35)

1. Stanhope R, Hindmarsh PC: Hazards of tests of'GH secretion, BMJ 1992:304:777-778.
2. Marin G, Domene HM, Barnes KM, Blackwell BH, Cassorla FG, Cutler GB: The effect of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys, J Clin Endocrinol Metab 1994:79: 537-541.
3. Rose SR, Ross JL, Uriartc M, Barnes KM, Cassorla FG, Cutler GB: The advantage of measur-ing stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency, N Engl J Med 1988;319:201-207.
4. Celnickcr AC, Chen AB, Wert RM, Sherman BM: Variability in the quantitation of circulating growth hormone using commercial immunoassays, J Clin Endocrinol Mctab 1989:68: 469-476.
5. Rosenfeld RG, Albeitsson-Wikland K, Cassorla F, Frasier SD, Hascgawa Y, Hint/, RL, La-franchi S, Lippe B, Loriaux L, Melmcd S: Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited, J Clin Endocrinol Metab 1995:80:1532-1540.
6. Gertner JM, Gencl M, Gianfredi SP, Hint RL, Rosenfeld RG, Tamborlane WV, Wilson DM: Prospective clinical trial of human growth hormone in short children without growth hormone deficiency, J Pediatr 1984:104:172-176.
7. Van Vlict B, Styne DM, Kaplan SL, Grumbach MM: Growth hormone treatment for short stature, N Engl J Med 1983:309:1016-1022.
8. Plotnick LP, Van Meter QL, Kowarski AA: Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay, Pediatrics 1983: 71:324-327.
9. Horner JM, Thorsson AV, Hintz RL: Growth deceleration patterns in constitutional short stature: An aid to diagnosis, Pediatrics 1978: 62:529-534.
10. Hint/, RL: Disorders of growth: in Lee P, San-filipo J (eds): Pediatric and Adolescent Gynecology, Philadelphia, Saunders, 1993, pp 34-43.
11. PfalTle RW, Parks JS, Brown MR, Hcimann G: Pit-1 and pituitary function, J Pediatr Endocrinol 1993:6:229-233.
12. Cogan JD, Ramcl B, Lehto M, Phillips J III, Prince M, Blizzard RM, dc Ravel TJ, Brant-mert M, Groop L: A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency - A clinical research center study, J Clin Endocrinol Metab 1995:80:3591-3595.
13. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K: Short stature caused by a mutant growth hormone, N Engl J Med 1996:334:432-436.
14. Laron Z: Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient, J Clin Endocrinol Metab 1995;80:1526-1531.
15. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P: Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls, Acta Paediatr Suppl 1994:399:117-124.
16. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency, Endocr Rev 1994:15:369-390.
17. Attie KM, Carlsson LM, Rundle AC, Sherman BM: Evidence for partial growth hormone insensitivity among patients with idiopathic short stature: The National Cooperative Growth Study, J Pediatr 1995:127:244-250.
18. Peoples R, Milatovich A, Francke U: Hemizy-gositv at the insulin-like growth factor-I receptor (IGF 1R) locus and growth failure in the ring chromosome 15 syndrome, Cvtogcnct Cell Genet 1995;70:228-234.
19. Ranke MB, Graucr ML, Kistner K, Blum WF, Woimann HA: Spontaneous adult height in idiopathic short stature, Horm Res 1995;44: 152-157.
20. Hintz RL, Attie KM, Johanson AJ, Baptista J, Roche AF and the Genentech Study Group: Near final height in GH-trcated short children without classical GH deficiency, Pediatr Res I995;37:A530.
21. Karlberg J, Lawrence C, Albertsson-Wikland K: Prediction of final height in short, normal and tall children, Acta Paediatr Suppl 1994; 406:3-9.
22. La Franchi S, Hanna CE, Mandel SH: Constitutional delay of growth: Expected versus final adult height, Pediatrics 1991:87:82-87.
23. Hindmarsh PC, Pringle PH, Di Sivio L, Brook CGD: Effects of 3 years of growth hormone therapy in short normal children, Acta Paediatr Scand Suppl 1990:336:6-12.
24. Takano K, Hizuka N, Asakawa K, Sukegawa I, Horikawa R, Shizume K: Effects of short-term growth hormone therapy in short children without growth hormone deficiency, Acta Paediatr Scand Suppl 1990:336:14-22.
25. Albertsson-Wikland K: Characteristics of children with idiopathic short stature in the Kabi-Pharmacia international growth study, and their response to growth hormone treatment, Acta Paediatr Suppl 1993;391:75-78.
26. Bicrich JR, Nolten K, Drews K, Brigmann G: Constitutional delay of growth and adolescence: Results of short term and long term treatment with growth hormone, Acta Endocrinol 1992:127:392-396.
27. Lanes R: Effects of two years of growth hormone treatment in short, slowly growing nongrowth hormone deficient children, J Pediatr Endocrinol Metab 1995:8:167-171.
28. Spagnoli A, Spadoni GL, Cianfarani S, Pasqui-no AM, Troiani S, Boscherini B: Prediction of the outcome of growth hormone therapy in children with idiopathic short stature: A multivariate discriminant analysis, J Pediatr 1995; 126:905-909.
29. Blizzard R, Cara J, Chemausek S, Gertner J, Hintz R, Ilopwood N, Kaplan S, Johanson A, Kirkland J, Lippe B, Plotnick L., Saenger P, Sherman BM: Idiopathic short stature: Results of a one-year controlled study of human growth hormone treatment, J Pediatr 1989:115:713-719.
30. Hopwood NJ, Hintz RL, Gertner JM, Attic KM, Johanson AJ, Baptista J, Kuntzc J, Blizzard RM, Cara JF, Chemausek SD, Kaplan SL, Lippe BM, Plotnick LP, Saenger P: Growth response of non-growth hormone deficient children with marked short stature during three years of growth hormone therapy, J Pediatr 1993;123:215-222.
31. Lochc S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M: Final height after growth hormone therapy in non-growth hormone deficient children with short stature, J Pediatr 1994:125:196-200.
32. Wit JM, Boersma B, deMuinckKeizer-Schra-ma SM, Nienhuis HE, Oostdijk W, Ottcn BJ, Delemarre-VandeWaal HA, Reeser M, Waelkens JJ, Rikken B, Massa GG: Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secreta-gogucs: Dutch Growth Homione Working Group, Clin Endocrinol 1995:42:365-372.
33. Zadik Z, Chalew S, Zung A, Landau H, Lciber-man E, Koren R, Voet H, Hochberg Z, Kowar-ski A: Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and w'ithout classic growth hormone deficiency, J Pediatr 1994:126:189-195.
34. Hindmarsh PC, Brook CGD: Final height is not improved in short normal children treated with growth hormone (abstract OR30-1), 77th Annu Meet Endocrine Soc, 1995.
35. Allen DB, Brook CGD, Bridges NA, Hindmarsh PC, Guvda HJ, Frazier D: Therapeutic controversies: Growth hormone (GH) treatment of non-GH deficient subjects, J Clin Endocrinol Metab 1994:79:1239-1248.